3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Lymphoid
3
Other hematologic neoplasm
2
Gastrointestinal
2
Thoracic
1
Plasma cell
1
Breast
1
Conditions
Colorectal Neoplasms
4
Pancreatic Neoplasms
2
Influenza, Human
2
Carcinoma, Non-Small-Cell Lung
2
Vaccine-Preventable Diseases
1
Vaccination Hesitancy
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Patient Acceptance of Health Care
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Melanoma
1
Lung Neoplasms
1
Hepatoblastoma
1
Health Behavior
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Merkel Cell
1
Carcinoma, Hepatocellular
1
COVID-19
1
Breast Neoplasms
1
Interventions
Influenza Vaccines
2
Nivolumab
1
Ipilimumab
1
Gastroscopy
1
Colonoscopy
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Influenza, Human
×
Influenza Vaccines
×
Gastrointestinal
×
Clear all
NCT06124131
2025-05-04
BENEFIT-C
Tulane University
Phase NA
Completed
50 enrolled
15 charts
NCT05116917
2024-05-28
INFLUENCE
Herlev Hospital
Phase 2
Terminated
19 enrolled